Cereno Scientific
231 subscribers
1:15:10
Cereno Scientific presents positive topline results of Phase IIa trial with CS1 in PAH
Cereno Scientific
572 views • 2 days ago
6:35
Dr. Michael Holinstat presents new preclinical data for CS585 at ESC Congress 2024
Cereno Scientific
273 views • 4 weeks ago
3:09
Cereno Scientific at ESC 2024
Cereno Scientific
804 views • 1 month ago
6:53
Insights Series S3E9: Cereno leading the way in HDAC inhibitors for CVD
Cereno Scientific
452 views • 6 months ago
6:45
Insights Series S3E8: Dr. Björn Dahlöf on HDAC inhibitors as an important potential therapy for CVD
Cereno Scientific
313 views • 6 months ago
1:29
Insights Series S3E7: Dr. Raymond Benza on Pulmonary Arterial Hypertension - Cereno at PVRI
Cereno Scientific
318 views • 6 months ago
27:34
Life Sciencedagen 2024
Cereno Scientific
483 views • 6 months ago
3:38
Insights Series S3 E6: Dr. Raymond Benza on HDAC inhibition in PAH
Cereno Scientific
353 views • 7 months ago
2:16
Insight Series S3 E5: Dr. Raymond Benza on Compassionate Use
Cereno Scientific
508 views • 7 months ago
2:50
Insights Series S3 E4: CEO Sten R. Sörensen about the future implications for PAH patients
Cereno Scientific
444 views • 7 months ago
5:30
Insights Series S3 E3: CEO Sten R. Sörensen on the exciting field of PAH
Cereno Scientific
395 views • 7 months ago
2:21
Insights Series S3 E2: CEO Sten R. Sörensen on “Compassionate use”
Cereno Scientific
436 views • 7 months ago
2:12
Insights Series S3 E1: CEO Sten R. Sörensen about the latest news for Cereno Scientific
Cereno Scientific
448 views • 7 months ago
3:19
Insights Series S2E8: Prof Benza about the move towards innovative trial designs in PAH studies
Cereno Scientific
503 views • 8 months ago
3:46
Insights Series S2E7: Prof Benza about the rationale and design of a Phase II clinical trial in PAH
Cereno Scientific
578 views • 8 months ago
1:28
Insights Series S2E6: P.Adamson, Abbott, on enhancing quality of life for patients with CardioMEMS™
Cereno Scientific
386 views • 9 months ago
1:24
Insights Series S2E5: Phil Adamson, Abbott, about personalized medicine in PAH with CardioMEMS™
Cereno Scientific
465 views • 11 months ago
0:59
Insights Series S2E4: Phil Adamson, Abbott, about CardioMEMS™ use in the CS1 clinical trial
Cereno Scientific
429 views • 11 months ago
1:48
Insights Series S2E3: P.Adamson, Abbott, on CardioMEMS and its utility in the study of heart failure
Cereno Scientific
380 views • 1 year ago
1:21
Insights Series S2E2: Prof. Benza about why CS1 is such an exciting drug candidate in PAH
Cereno Scientific
700 views • 1 year ago
4:42
Insights Series S2E1: Prof. Benza on remarkable patient case study data from Phase II study of CS1
Cereno Scientific
1.1K views • 1 year ago
2:10:10
Cereno Scientific's Capital Markets Day 2023
Cereno Scientific
2.2K views • 1 year ago
2:50
Cereno at ESC 2023: Our CEO speaks about the latest updates in our Phase II study of CS1 in PAH.
Cereno Scientific
348 views • 1 year ago
1:03
ESC 2023 congress: Sten R. Sörensen, CEO, shares his take on the hottest news in Cereno right now
Cereno Scientific
114 views • 1 year ago
1:24
ESC 2023 congress: Our CMO Björn Dahlöf about the great opportunities that the congress brings
Cereno Scientific
97 views • 1 year ago
0:41
Cereno at the ESC 2023 congress! Our CEO Sten R. Sörensen talks about the congress.
Cereno Scientific
90 views • 1 year ago
7:07
Meet Cereno's CEO Sten R. Sörensen
Cereno Scientific
376 views • 1 year ago
16:55
Insights Series: PAH and CardioMEMS collaboration from Abbott's perspective
Cereno Scientific
212 views • 1 year ago
10:55
Insights Series: Prof. Benza about Cereno's Clinical Phase II Trial with CS1
Cereno Scientific
227 views • 1 year ago
9:37
Insights Series: Clinical Trials in PAH
Cereno Scientific
246 views • 1 year ago
Load More